Cargando…

COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report

BACKGROUND: Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B virus (HBV) reactivation occurring in COVID-19 patients has not yet been reported. CASE S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yi-Feng, Yu, Wan-Jun, Jiang, Yu-Hua, Chen, Yin, Zhang, Bo, Zhen, Rui-Bing, Zhang, Jun-Tao, Wang, Yi-Ping, Li, Qiang, Xu, Feng, Shi, Yan-Jun, Li, Xian-Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283611/ https://www.ncbi.nlm.nih.gov/pubmed/34307577 http://dx.doi.org/10.12998/wjcc.v9.i19.5266

Ejemplares similares

Roles of Hepatitis B Virus Mutations in the Viral Reactivation after Immunosuppression Therapies
por: Inoue, Jun, et al.
Publicado: (2019)

Patients with Coexistence of Circulating Hepatitis B Surface Antigen and Its Antibody May Have a Strong Predisposition to Virus Reactivation During Immunosuppressive Therapy: A Hypothesis
por: Chen, Yu-Lan, et al.
Publicado: (2017)

Prevention of Hepatitis B reactivation in the setting of immunosuppression
por: Pattullo, Venessa
Publicado: (2016)

Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients
por: Cheng, Rui-Juan, et al.
Publicado: (2019)

Calcium-Related Gene Signatures May Predict Prognosis and Level of Immunosuppression in Gliomas
por: Liu, Peidong, et al.
Publicado: (2022)

Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment
por: Tsai, Yu-Fen, et al.
Publicado: (2021)

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
por: Lau, George, et al.
Publicado: (2021)

Therapeutic effects of pentoxifylline on invasive pulmonary aspergillosis in immunosuppressed mice
por: Feng, Chunlai, et al.
Publicado: (2021)

Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
por: Lau, George, et al.
Publicado: (2022)

Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy
por: Shih, Chih-An, et al.
Publicado: (2021)

Reactive Oxygen Species Mediated Prostaglandin E(2) Contributes to Acute Response of Epithelial Injury
por: Hu, Yi-Ping, et al.
Publicado: (2017)

Natural borneol is a novel chemosensitizer that enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage
por: Liu, Wen-Jian, et al.
Publicado: (2018)

Comparison of hematopoietic stem cell transplantation and immunosuppressive therapy as the first-line treatment option for patients with severe hepatitis−associated aplastic anemia
por: Zhang, Xiaoyu, et al.
Publicado: (2023)

Blockade of ICAM-1 Improves the Outcome of Polymicrobial Sepsis via Modulating Neutrophil Migration and Reversing Immunosuppression
por: Zhao, Yan-jun, et al.
Publicado: (2014)

Physapruin A Induces Reactive Oxygen Species to Trigger Cytoprotective Autophagy of Breast Cancer Cells
por: Yu, Tzu-Jung, et al.
Publicado: (2022)

Autoimmune Hepatitis-related Cirrhosis: Clinical Features and Effectiveness of Immunosuppressive Treatment in Chinese Patients
por: Li, Yan-Ni, et al.
Publicado: (2016)

Methylenetetrahydrofolate Reductase 677TT Genotype may be Associated with an Increased Lung Cancer Risk in North China: An Updated Meta
por: Liu, Nan-Bo, et al.
Publicado: (2014)

Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression
por: Liu, Yuan-Yuan, et al.
Publicado: (2015)

Successful treatment of tofacitinib in a case with rheumatoid arthritis who experienced hepatitis B virus reactivation induced by tocilizumab and recovered from entecavir rescue therapy
por: Huang, Jin-Xian, et al.
Publicado: (2020)

Plasma Sphingolipids as Potential Indicators of Hepatic Necroinflammation in Patients with Chronic Hepatitis C and Normal Alanine Aminotransferase Level
por: Li, Jun-Feng, et al.
Publicado: (2014)

Epstein–Barr-virus-associated hepatitis with aplastic anemia: A case report
por: Zhang, Wan-Jun, et al.
Publicado: (2022)

Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2(+) T cells activities after hematopoietic transplantation for blood malignancies
por: Liu, Jiangying, et al.
Publicado: (2020)

Dopant triggered atomic configuration activates water splitting to hydrogen
por: Wu, Rui, et al.
Publicado: (2023)

Spinosin ameliorates insulin resistance by suppressing reactive oxygen species-associated inflammation
por: Ge, Chi-yu, et al.
Publicado: (2022)

Deregulated bile acids may drive hepatocellular carcinoma metastasis by inducing an immunosuppressive microenvironment
por: Xia, Jin-kun, et al.
Publicado: (2022)

Correlation of Sexual Behavior Change, Family Function, and Male-Female Intimacy Among Adults Aged 18-44 Years During COVID-19 Epidemic
por: Feng, Yi-Jin, et al.
Publicado: (2021)

Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression
por: Lazarevic, Ivana, et al.
Publicado: (2019)

Hepatitis B reactivation in patients with pemphigus vulgaris after immunosuppressive therapy including rituximab
por: Yoo, Dae San, et al.
Publicado: (2020)

Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases
por: Onorato, Lorenzo, et al.
Publicado: (2021)

NADPH Oxidase 1 and Its Derived Reactive Oxygen Species Mediated Tissue Injury and Repair
por: Fu, Xiu-Jun, et al.
Publicado: (2014)

Treatment of ursodeoxycholic acid with glucocorticoids and immunosuppressants may improve the long-term survival rate in primary biliary cholangitis patients
por: Wang, Zi-Long, et al.
Publicado: (2022)

Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing
por: Bai, Yi, et al.
Publicado: (2022)

DNA methylation of DKK‐1 may correlate with pathological bone formation in ankylosing spondylitis
por: Zou, Yu‐Cong, et al.
Publicado: (2023)

Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy—a report of long-term follow-up of serial cases and literature review
por: Xuan, Dandan, et al.
Publicado: (2013)

Serum leptin levels may be correlated with cerebral infarction
por: Li, Kun-Bin, et al.
Publicado: (2016)

BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer
por: Liu, Jia-Zhou, et al.
Publicado: (2020)

Copper Chaperone for Superoxide Dismutase FoCCS1 in Frankliniella occidentalis May Be Associated with Feeding Adaptation after Host Shifting
por: Zhang, Tao, et al.
Publicado: (2022)

Early tapering of immunosuppressive agents after HLA-matched donor transplantation can improve the survival of patients with advanced acute myeloid leukemia
por: Yang, Jun, et al.
Publicado: (2017)

Prediction of hepatic necroinflammatory activity in patients with chronic hepatitis B by a simple noninvasive model
por: Shen, Fei-Fei, et al.
Publicado: (2018)

CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells
por: Zhang, Yuhan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2ggr18kl9vl6lrsgokhaml1p9t